Skip to Main content Skip to Navigation
Journal articles

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia

Thomas Briot 1, 2 Emilie Roger 2 Nolwenn Lautram 2 Alexis Verger 2 Anne Clavreul 3, 4 Frédéric Lagarce 1, 2
1 Département de Pharmacie [CHU Angers]
2 MINT - Micro et Nanomédecines Translationnelles
3 CRCINA-ÉQUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
4 Département de Neurochirurgie [CHU Angers]
Document type :
Journal articles
Complete list of metadatas

Cited literature [46 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-01668530
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, December 20, 2017 - 10:07:49 AM
Last modification on : Wednesday, November 4, 2020 - 11:24:02 AM

File

Vignette du document
ClavreulEq17.pdf
Files produced by the author(s)

Identifiers

Collections

CNRS | UNIV-ANGERS | UNIV-NANTES | CRCINA | UNAM | INC-CNRS | MINT | CRCINA-GLIAD

Citation

Thomas Briot, Emilie Roger, Nolwenn Lautram, Alexis Verger, Anne Clavreul, et al.. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia. International Journal of Nanomedicine, Dove Medical Press, 2017, Volume 12, pp.8427 - 8442. ⟨10.2147/IJN.S147659⟩. ⟨inserm-01668530⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

200

Files downloads

342